围手术期集束化措施是否与良性子宫切除术后并发症减少相关?密歇根州16286例回顾性队列分析
该回顾性队列分析纳入密歇根外科质量协作组2013年1月至2015年1月共16286例子宫全切术,评估4项围手术期措施(指南适宜预防性抗生素、微创入路、手术时间<120分钟、避免术中止血剂)组成的集束化评分与30天并发症及再入院的关系。结果显示,校正混杂因素后,满足全部4项标准的病例与未满足者相比,任何并发症、主要并发症及再入院率均更高(P<.001);医院层面满足全部4项标准的比例越高,术后并发症和再入院率越低(P<.001)。作者认为该集束化措施为手术目标,非每例均可实现,需前瞻性研究验证。
要点
- 33.6%的子宫全切术满足全部4项集束化标准,56家医院间差异大(最低四分位9.1%,最高四分位60.4%)。
- 校正混杂因素后,满足全部标准者任何并发症4.3-7.8%、主要并发症1.7-2.6%、再入院2.6-4.1%(均P<.001)。
- 医院层面满足全部4项标准的比例越高,术后并发症和再入院率越低(均P<.001)。
核心结论
- 多机构评估显示,并发症和再入院减少与集束化措施依从率相关。
- 所提出的集束化措施是手术目标,并非每例均可实现,密歇根医院间满足全部4项标准的病例比例差异显著。
- 在医疗系统层面实施循证集束化措施值得前瞻性研究,以确定能否改善患者结局。
研究设计与样本
- 回顾性队列分析,使用密歇根外科质量协作组子宫切除倡议的30天围手术期和术后结局数据。
- 纳入2013年1月至2015年1月期间实施的所有良性子宫全切术,共16286例,来自56家医院。
- 集束化评分由4项围手术期措施组成:指南适宜预防性抗生素使用、微创手术入路、手术时间<120分钟、避免术中止血剂使用;每项存在或不存在,评分0-4分,评分为0的病例被排除。
主要发现
- 全部子宫全切术中,33.6%满足全部集束化标准;56家医院中最低四分位医院为9.1%,最高四分位医院为60.4%。
- 总体任何并发症发生率为6.8%,任何主要并发症发生率为2.3%,再入院率为3.6%。
- 校正混杂因素后,满足全部集束化标准与未满足者相比,任何并发症发生率从4.3%升至7.8%(P<.001),主要并发症从1.7%升至2.6%(P<.001),再入院从2.6%升至4.1%(P<.001)。
- 校正混杂因素后,医院层面满足全部4项标准的比例越高,术后并发症率(P<.001)和再入院率(P<.001)越低。
关键数值与推荐
- 集束化措施包括:使用指南适宜的预防性抗生素、微创手术入路、手术时间<120分钟、避免术中止血剂使用。
- 主要并发症包括急性肾衰竭、需心肺复苏的心脏骤停、中心静脉导管感染、脑血管意外、死亡、深静脉血栓、肠梗阻、心肌梗死、盆腔脓肿、肺栓塞、直肠阴道瘘、脓毒症、手术部位感染(深部和器官腔隙)、非计划插管、输尿管梗阻、输尿管阴道瘘和膀胱阴道瘘。
- 任何并发症包括上述所有事件,外加术后72小时内输血、尿路感染和表浅手术部位感染。
临床怎么用
- 作者认为,在医疗系统层面实施循证集束化措施值得前瞻性研究,以确定能否改善患者结局。
- 作者指出,所提出的集束化措施是手术目标,并非每例均可实现。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Healthcare teams that frequently follow a bundle of evidence-based processes provide care with lower rates of morbidity. Few process bundles to improve surgical outcomes in hysterectomy have been identified. OBJECTIVE: The purpose of this study was to investigate whether a bundle of 4 perioperative care processes is associated with fewer postoperative complications and readmissions for hysterectomies in the Michigan Surgical Quality Collaborative. STUDY DESIGN: A bundle of perioperative care process goals was developed retrospectively with 30-day peri- and postoperative outcome data from the Hysterectomy Initiative in Michigan Surgical Quality Collaborative. All benign hysterectomies that had been performed between January 2013 and January 2015 were included. Based on evidence of lower complication rates after benign hysterectomy, the following processes were considered to be the "bundle": use of guideline-appropriate preoperative antibiotics, a minimally invasive surgical approach, operative duration <120 minutes, and avoidance of intraoperative hemostatic agent use. Each process was considered present or absent, and the number of processes was summed for a bundle score that ranged from 0-4. Cases with a score of zero were excluded. Outcomes measured were rates of complications (any and major) and hospital readmissions, all within 30 days of surgery. Postoperative events that were considered a "major complication" included acute renal failure, cardiac arrest that required cardiopulmonary resuscitation, central line infection, cerebral vascular accident, death, deep vein thrombosis, intestinal obstruction, myocardial infarction, pelvic abscess, pulmonary embolism, rectovaginal fistula, sepsis, surgical site infection (deep and organ-space), unplanned intubation, ureteral obstruction, and ureterovaginal and vesicovaginal fistula. The outcome "any complication" included all those events already described in addition to blood transfusion within 72 hours of surgery, urinary tract infection, and superficial surgical site infection. Outcomes were adjusted for patient demographics, surgical factors, and hospital-level clustering effects. RESULTS: There were 16,286 benign hysterectomies available for analysis. Among all hysterectomies that were reviewed, 33.6% met criteria for all bundle processes; however, there was wide variation in the rate among the 56 hospitals in the study sample with 9.1% of cases at the lowest quartile and 60.4% at the highest quartile of hospitals that met criteria for all bundle processes. Overall, the rate of any complication was 6.8% and of any major complication was 2.3%. The rate of hospital readmissions was 3.6%. After adjustment for confounders, in cases in which all bundle criterion were met compared with cases in which all bundle criterion were not met, the rate of any complications increased from 4.3-7.8% (P<.001); major complications increased from 1.7-2.6% (P<.001), and readmissions increased from 2.6-4.1% (P<.001). After adjustment for confounders, hospitals with greater rates of meeting all 4 criteria were associated significantly with lower hospital-level rates of postoperative complications (P<.001) and readmissions (P<.001). CONCLUSIONS: This multiinstitutional evaluation reveals that reduced morbidity and readmission are associated with rates of bundle compliance. The proposed bundle is a surgical goal, which is not possible in every case, and there is significant variation in the proportion of cases meeting all 4 bundle processes in Michigan hospitals. Implementation of evidence-based process bundles at a healthcare system level are worthy of prospective study to determine whether improvements in patient outcomes are possible.
引用
- Harris JA, Sammarco AG, Swenson CW, et al. Are perioperative bundles associated with reduced postoperative morbidity in women undergoing benign hysterectomy? Retrospective cohort analysis of 16,286 cases in Michigan. Am J Obstet Gynecol. 2017. PMID: 28082214. doi:10.1016/j.ajog.2016.12.173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。